Prevalence and Associated Factors of PTSD Symptoms After the COVID-19 Epidemic Outbreak in an Online Survey in China: The Age and Gender Differences Matter-Reference-Cited by-同舟云学术

Prevalence and Associated Factors of PTSD Symptoms After the COVID-19 Epidemic Outbreak in an Online Survey in China: The Age and Gender Differences Matter

Published:2022-04 Issue: Volume:Volume 18 Page:761-771
ISSN:1178-2021
Container-title:Neuropsychiatric Disease and Treatment
language:en
Short-container-title:NDT

Author:

Mao Jiankai,Wang Chaoyue,Teng Chao,Wang Mengpu,Zhou Siyao,Zhao Ke,Ye Xiangming,Wang Yijia

Publisher

Informa UK Limited

Reference52 articles.

1. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status

2. COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Available from: https://coronavirus.jhu.edu/map.html. Accessed November 8, 2020.

3. Epidemic of COVID-19 in China and associated Psychological Problems

4. A novel coronavirus outbreak of global health concern

5. The psychological impact of quarantine and how to reduce it: rapid review of the evidence

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of long COVID-19 on posttraumatic stress disorder as modified by health literacy: an observational study in Vietnam;Osong Public Health and Research Perspectives;2024-02-29

2. Association between burnout and post‐traumatic stress disorder among frontline nurse during COVID‐19 pandemic: A moderated mediation analysis;Journal of Clinical Nursing;2023-12

3. Acute stress symptoms in general population during the first wave of COVID lockdown in Italy: Results from the COMET trial;Brain and Behavior;2023-11-21

4. Long COVID, the Brain, Nerves, and Cognitive Function;Neurology International;2023-07-06

5. Validation of the Spanish Version of the Trauma and Loss Spectrum Self-Report (TALS-SR): A Study on Healthcare Workers Facing the COVID-19 Pandemic;Neuropsychiatric Disease and Treatment;2023-03